Growth momentum CREO is a growing life sciences and healthcare consulting firm aligned with private equity portfolio companies, recently recognized on the Inc. 5000 list for four consecutive years and backed by an investment from Grant Avenue Capital, signaling strong expansion potential and demand for strategic, regulatory, and digital transformation services.

Strategic cross-sell With capabilities spanning Strategy, M&A, Digital Transformation, Cybersecurity, and IT Quality & Regulatory Compliance, CREO offers a broad portfolio that can be cross-sold to existing life sciences, healthcare, and PE-backed clients seeking end-to-end operational and clinical innovation improvements.

PE-backed growth Investment from a healthcare-focused private equity firm suggests CREO’s services as a value driver for portfolio companies; sales can target firms within Grant Avenue Capital’s network and other PE-backed life sciences and healthcare entities seeking vendor consolidation and scale.

Tech-enabled delivery Adopted tech stack including SAP S/4HANA, Oracle Cloud, Tableau, Power BI, and cybersecurity/compliance frameworks positions CREO to engage clients undertaking digitalization, data analytics, ERP migrations, or cybersecurity uplift projects.

Regional focus Headquartered in Durham, NC with a national and international client base indicates readiness to scale sales outreach in life sciences hubs and adjacent markets while leveraging a mid-sized firm flexibility favored by PE-backed clients and growth-stage companies.